Outcome and resource use associated with myomectomy.

Area of Science:

• Gynecology
• Health Economics

Background:

• Uterine leiomyomas (fibroids) are common benign tumors affecting women of reproductive age.
• Myomectomy is a surgical procedure to remove fibroids while preserving the uterus.

Purpose of the Study:

• To evaluate the long-term outcomes and associated costs of myomectomy using retrospective insurance claims data.
• To assess the impact of repeat procedures on the total healthcare expenditure following myomectomy.

Main Methods:

• Retrospective analysis of private insurance claims data from 1995 to 1997.
• Identification of patients undergoing myomectomy using ICD-9-CM and CPT-4 codes.
• Estimation of inpatient, outpatient, and physician costs, adjusted to 1997 dollars.

Main Results:

• Abdominal myomectomy was the most frequent procedure, followed by hysteroscopic and laparoscopic approaches.
• 5.4% of patients required conversion to a more invasive procedure during the initial surgery.
• The rate of additional surgeries increased over time, reaching 16.5% within two years.
• Total patient costs rose from $6,737 initially to $8,001 at two years post-procedure.

Conclusions:

• Repeat surgeries following myomectomy significantly contribute to the overall healthcare costs.
• Evaluating post-myomectomy healthcare utilization is essential for comprehensive cost assessment.
• This analysis provides a basis for comparing myomectomy with alternative uterine fibroid treatments.